JD
Joyshree Deb Nath
About Joyshree Deb Nath
Data last updated:
Joyshree Deb Nath is a Director at Lupikem Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Lupikem Pharmaceuticals Private Limited reported revenue of ₹3.3 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 07 Nov 2023 | 2023 | ₹3.3 Lakh (FY 2025) | Active |
Board colleagues of Joyshree Deb Nath
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arjun Nath | 10384989 | Lupikem Pharmaceuticals Private Limited | Director |
| Swapan Nath | 10384987 | Lupikem Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Joyshree Deb Nath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Joyshree Deb Nath
Joyshree Deb Nath currently holds 1 directorship: Lupikem Pharmaceuticals Private Limited (Director, since 07 Nov 2023, revenue ₹3.3 Lakh (FY 2025)).
Joyshree Deb Nath was first appointed on 07 Nov 2023 as Director at Lupikem Pharmaceuticals Private Limited.
The current boards of Joyshree Deb Nath's companies include Arjun Nath (Lupikem Pharmaceuticals Private Limited), Swapan Nath (Lupikem Pharmaceuticals Private Limited).